131 related articles for article (PubMed ID: 36843430)
1. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
2. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative ADC predicts early recurrence of HCC after curative resection.
Lee S; Kim SH; Hwang JA; Lee JE; Ha SY
Eur Radiol; 2019 Feb; 29(2):1003-1012. PubMed ID: 30027408
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M; Link H; Hirner-Eppeneder H; Alunni-Fabbroni M; Wildgruber M; Salvermoser L; Corradini S; Schinner R; Ben Khaled N; Rössler D; Galun E; Goldberg SN; Ricke J; Kazmierczak PM
Radiat Oncol; 2023 Jul; 18(1):125. PubMed ID: 37507808
[TBL] [Abstract][Full Text] [Related]
6. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation.
Chuang YH; Ou HY; Yu CY; Chen CL; Weng CC; Tsang LL; Hsu HW; Lim WX; Huang TL; Cheng YF
Cancer Imaging; 2019 Nov; 19(1):74. PubMed ID: 31730015
[TBL] [Abstract][Full Text] [Related]
8. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging during MR-guided radiofrequency ablation of hepatic malignancies: analysis of immediate pre- and post-ablative diffusion characteristics.
Hoffmann R; Rempp H; Schraml C; Schwenzer N; Grözinger G; Blumenstock G; Rothgang E; Pereira PL; Claussen CD; Clasen S
Acta Radiol; 2015 Aug; 56(8):908-16. PubMed ID: 25182804
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
[TBL] [Abstract][Full Text] [Related]
11. Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules.
Heinze C; Damm R; Othmer M; Thormann M; Surov A; Hass P; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M; Omari J
Brachytherapy; 2023; 22(2):231-241. PubMed ID: 36697267
[TBL] [Abstract][Full Text] [Related]
12. Utility of Early Posttreatment PET/CT Evaluation Using FDG or
Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A
AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448
[No Abstract] [Full Text] [Related]
13. Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma.
Surov A; Pech M; Omari J; Fischbach F; Damm R; Fischbach K; Powerski M; Relja B; Wienke A
Liver Cancer; 2021 Feb; 10(1):10-24. PubMed ID: 33708636
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
[TBL] [Abstract][Full Text] [Related]
16. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
17. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
18. Local ablation of hepatocellular carcinoma by interstitial brachytherapy: prediction of outcome by diffusion-weighted imaging.
Thormann M; Surov A; Pech M; March C; Hass P; Damm R; Omari J
Acta Radiol; 2023 Apr; 64(4):1331-1340. PubMed ID: 36262039
[TBL] [Abstract][Full Text] [Related]
19. The Roles of Diffusion Kurtosis Imaging and Intravoxel Incoherent Motion Diffusion-Weighted Imaging Parameters in Preoperative Evaluation of Pathological Grades and Microvascular Invasion in Hepatocellular Carcinoma.
Wang F; Yan CY; Wang CH; Yang Y; Zhang D
Front Oncol; 2022; 12():884854. PubMed ID: 35646649
[TBL] [Abstract][Full Text] [Related]
20. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
